Biotechnology Invest Information

Stocks
Investor Alert: Faruqi & Faruqi, LLP Announces Investigation on Behalf of Metagenomi Shareholders Oct 1, 2024
Companies
Unicycive Therapeutics Announces Participation in H.C. Wainwright Investment Conference Sep 6, 2024
Stocks
Bionomics Limited to Exhibit at the H.C. Wainwright Global Investment Conference Sep 4, 2024
Stocks
Unicycive Therapeutics to Feature Prominently at ASN Kidney Week 2024 Aug 27, 2024
Stocks
Boundless Bio, Inc. (BOLD) Presents a Buying Opportunity After Recent Dip Aug 14, 2024
Companies
FDA Grants Anixa Biosciences' Individual Patient IND for Second Dose of CAR-T Ovarian Cancer Therapy Jul 23, 2024
Biotechnology
Gain Therapeutics Presents Key Data on GT-02287 at FENS Forum 2024 Jun 27, 2024
Companies
argenx Unfolds its Long-term Plan 'Vision 2030' to Bring Breakthrough Science to Thousands of Patients Jun 18, 2024
Companies
Molecular Partners AG to Participate in The TD Cowen Radiopharmaceutical Innovation Summit Jun 18, 2024
Markets
Gain Therapeutics Proposes Public Offering of Common Stock Jun 14, 2024
Stocks
Gain Therapeutics Sets Price for $11.0 Million Public Stock Offering Jun 14, 2024
Companies
Eisai Submits LEQEMBI® (lecanemab-irmb) Biologics License Update to FDA for Early Alzheimer's Treatment – Biogen Stocks in Focus Jun 10, 2024
Analysis
CASI Pharmaceuticals Targets Stability with 'Hold' Rating from Investment Analysts Jun 1, 2024
Stocks
Puma Biotechnology PBYI Downgraded to Hold by StockNews.com Analysts May 12, 2024
Biotechnology
Belite Bio's Tinlarebant Gains Spotlight at ARVO 2024 for Potential Treatment of Stargardt Disease and Dry AMD May 2, 2024
Companies
Pluri Inc. Develops Cell-Based Coffee Innovation in Wake of Fluctuating Coffee Market Conditions Mar 21, 2024
Companies
Charles River (CRL) Anticipated to Reveal Growth in Q4 Earnings Feb 2, 2024
Markets
Agricultural Biotechnology Market on the Rise: Expected to Hit USD 64.7 Billion by 2031 Jan 20, 2024
Companies
Novartis Scemblix® Outperforms Traditional TKIs in Phase III CML Trial Jan 8, 2024
Companies
Molecular Partners and Orano Med Forge Partnership for Novel Radio-DARPin Therapies Development Jan 6, 2024
Companies
Investor Alert: Deadline Approaches in SCYNEXIS (NASDAQ:SCYX) Class Action Lawsuit Dec 27, 2023
Stocks
The Pioneering Developments Reshaping Investment Landscapes Dec 26, 2023
Earnings
Microbix Reports Financial Performance for Fiscal Year 2023 Dec 22, 2023
Companies
Zealand Pharma Enhances Board with Pharmaceutical Industry Stalwarts Enrique Conterno and Elaine Sullivan Dec 1, 2023
Biotechnology
Sernova Granted FDA Orphan Drug and Rare Pediatric Disease Designations for Hemophilia A Treatment Nov 28, 2023
Biotechnology
PharmAbcine's PMC-403 Shows Promise in Preclinical Study for Idiopathic Systemic Capillary Leak Syndrome Nov 24, 2023
Finance
Rosen Law Firm Advocates for SCYNEXIS Investors Ahead of Legal Deadline Nov 19, 2023
Companies
Microbix to Engage with Investors at the Upcoming Florida Capital Event Conference Nov 18, 2023
Stocks
SCYNEXIS Rating Adjustment: Downgraded to Hold Nov 17, 2023
Biotechnology
IHG PAS Partners with SOPHiA GENETICS to Further Male Infertility Research Nov 17, 2023
Companies
Olink Holding AB Announces Q3 2023 Financial Performance Nov 16, 2023
Biotechnology
Athira Pharma Showcases Neuroprotective Properties of Fosgonimeton in Alzheimer's Disease Models Nov 16, 2023
Companies
Yield10 Bioscience's Stacked Herbicide Tolerant Camelina Granted Planting and Breeding Approval in U.S. Nov 15, 2023
Finance
Aeglea BioTherapeutics AGLE Receives Sell Rating Amid Market Dynamics Nov 13, 2023
Stocks
vTv Therapeutics Receives a 'Hold' Rating from StockNews.com Analysts Nov 12, 2023
Stocks
ROSEN, Trial Attorneys Urge SCYNEXIS Investors to Act Before Critical Securities Class Action Deadline - SCYX Nov 12, 2023
GENFIT Announces Third Quarter 2023 Financial Outcomes and Update on R&D Progress Nov 10, 2023
PetVivo Holdings, Inc. Set to Unveil Q2 Financial Results and Conduct a Conference Call Nov 9, 2023
Pasithea Therapeutics Advances ALS Treatment with New Lead Candidate PAS-003 Targeting α5β1 Integrin Nov 9, 2023
Catalyst Pharmaceuticals Delivers Mixed Q3 Results While Raising 2023 Outlook Nov 9, 2023